G

Genelux Corp
NASDAQ:GNLX

Watchlist Manager
Genelux Corp
NASDAQ:GNLX
Watchlist
Price: 2.48 USD 2.48%
Market Cap: 93.6m USD

Wall Street
Price Targets

GNLX Price Targets Summary
Genelux Corp

Wall Street analysts forecast GNLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNLX is 18.36 USD with a low forecast of 8.08 USD and a high forecast of 31.5 USD.

Lowest
Price Target
8.08 USD
226% Upside
Average
Price Target
18.36 USD
640% Upside
Highest
Price Target
31.5 USD
1 170% Upside
Genelux Corp Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
18% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
51% Downside
6855
Ascentage Pharma Group International
19% Upside
302440
SK Bioscience Co Ltd
10% Upside
ALT
Altimmune Inc
300% Upside
TSHA
Taysha Gene Therapies Inc
155% Upside
GILD
Gilead Sciences Inc
11% Upside
BIIB
Biogen Inc
37% Upside

Revenue
Forecast

Revenue Estimate
Genelux Corp

The compound annual growth rate of Genelux Corp's revenue for the next 3 years is 1 590%.

N/A
Past Growth
1 590%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genelux Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Genelux Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GNLX's stock price target?
Price Target
18.36 USD

According to Wall Street analysts, the average 1-year price target for GNLX is 18.36 USD with a low forecast of 8.08 USD and a high forecast of 31.5 USD.

What is Genelux Corp's Revenue forecast?
Projected CAGR
1 590%

The compound annual growth rate of Genelux Corp's revenue for the next 3 years is 1 590%.

Back to Top